William Howell


United States
Also Known As
Chief Medical Officer at Tackle Bio, Inc

Chief Medical Officer at Tackle Bio, Inc Wrote clinical, pharmacokinetic, and mechanism of action sections of pre-Investigational New Drug (pre-IND) FDA application for repurposed drug targeting COVID-19. Wrote portions of draft clinical protocol for the FDA as well as edited the protocol and pre-IND. Proposed pre-clinical mouse studies to further refine mechanisms of action and pharmacokinetics of drug. Wrote portions of provisional patent. Provided clinical and scientific guidance. https://www.bloomberg.com/press-releases/2021-03-18/cps-health-care-and-telewellness-present-the-rating-of-covid-technologies-on-a-lifetime-award

Voted (0)

Works (0)

Video (0)

News about William Howell(0)

Join our Telegram Channel!